I hold my nose and prescribe.
How much money does the manufacturer of Valtoco make?
The manufacturer of Valtoco, Neurelis, Inc., generated an estimated $295 million to $300 million in net sales for the full year of 2025. Because Valtoco is their flagship commercial product, it drives the vast majority of this revenue.
A breakdown of Neurelis' financial performance highlights their latest earnings structure:
Net Sales Growth: The $295–$300 million figure for 2025 represents an immense jump, more than doubling their 2024 net sales figures.
Profitability: The company reported an EBITDA margin of 30%+, meaning their core operating profitability is roughly $90 million or more before accounting for interest, taxes, depreciation, and amortization.Cash Reserves: As of December 31, 2025, Neurelis held $175+ million in cash with zero bank debt.
Growth Catalysts: Sales spiked dramatically following the FDA indication expansion allowing children ages 2 to 5 to be prescribed the nasal spray.
Google AI
______________________________________________________
Why is Valtoco so expensive?
AI Overview
Valtoco is expensive because it is a brand-name medication with no generic alternative. Its high cost reflects the years of research and clinical trials required to develop its specialized, needle-free nasal delivery system, alongside the proprietary Intravail absorption technology.
Because it is a patented pharmaceutical manufactured by Neurelis, there are no competitors to drive down the retail price, which can easily exceed $380 to $1,000+ depending on the prescribed dosage. However, according to discussion on the r/Epilepsy Reddit Forum, users agree that the prohibitive retail prices can be bypassed using manufacturer savings programs and patient assistance programs, often bringing costs down significantly.
Patients prescribed Valtoco can utilize several tools to reduce their out-of-pocket costs:
Manufacturer Co-Pay Cards: Patients with commercial insurance can often pay as little as $20 through the VALTOCO Co-Pay Card Program.
Patient Assistance Programs: Uninsured or underinsured patients may qualify to receive the medication at no cost through the myNEURELIS Support Program.
Discount Cards: Using tools like the GoodRx Valtoco Page can also provide pharmacy coupons that drop the cash price well below retail.
Google AI
____________________________________________________________
No comments:
Post a Comment